Pioneer 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes
Statin use changes the gut microbiome in a way that reduces GLP-1 production.[ref] Statins are one of the top drugs prescribed each year
It is a free, quick, easy, and reliable type of measurement, but it should always be considered along with other individual factors, such as blood pressure, cholesterol levels, and labs
At present, the GLP-1 receptor agonists exendin-4 (Exenatide, Byetta , Bydureon ) (44, 45), liraglutide (Victoza ) (46), albiglutide [Eperzan (EU) Tanzeum (US)] (47, 48), dulaglutide (Trulicity ) (49), lixisenatide (Lyxumia , Adlyxin ) (50), semaglutide (Ozempic , Rybelsus ) (51, 52), are approved to treat T2DM (53) (see Table 1)